Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Weight gain and metabolic abnormalities are a growing concern for people with HIV as they age, raising the risk for cardiovascular disease, fatty liver disease and other health problems
GHK-Cu for Skin: In skincare, GHK-Cu stimulates fibroblasts to produce collagen and elastin, reduces hyperpigmentation, and improves skin elasticity
Reduction in major cardiovascular events (SELECT trial, semaglutide) Reduced risk of progressing from prediabetes to type 2 diabetes (Tirzepatide, 3yr trial) Weight reduction significantly improves sleep apnea severity confirmed in multiple GLP-1 trials Emerging ADA 2026 data on GLP-1 anti-inflammatory effects and osteoarthritis improvement Improved basal metabolic rate and energy utilisation, especially with tirzepatides GIP pathway We believe cost transparency is part of quality care
Nausea may emerge, usually mild and often resolving within 1-2 weeks as your body adapts
